scispace - formally typeset
T

Takahiro Ochiya

Researcher at National Cancer Research Institute

Publications -  356
Citations -  25876

Takahiro Ochiya is an academic researcher from National Cancer Research Institute. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 64, co-authored 309 publications receiving 19828 citations. Previous affiliations of Takahiro Ochiya include Toray Industries & Osaka University.

Papers
More filters
Journal ArticleDOI

Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

Clotilde Théry, +417 more
TL;DR: The MISEV2018 guidelines include tables and outlines of suggested protocols and steps to follow to document specific EV-associated functional activities, and a checklist is provided with summaries of key points.
Journal ArticleDOI

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.

TL;DR: The usefulness of circulating miRNA for cancer diagnosis, prognosis, and therapeutics is summarized and a mechanism for the secretion and incorporation of miRNA into the cells is proposed.
Journal ArticleDOI

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

Thomas Lener, +57 more
TL;DR: In this paper, the authors summarize recent developments and the current knowledge of extracellular vesicles (EVs) and discuss safety and regulatory requirements that must be considered for pharmaceutical manufacturing and clinical application.
Journal ArticleDOI

Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis.

TL;DR: It is demonstrated that the neutral sphyngomyelinase 2 (nSMase2) regulates exosomal microRNA (miRNA) secretion and promotes angiogenesis within the tumor microenvironment as well as metastasis, suggesting that the horizontal transfer of exosome miRNAs from cancer cells can dictate the microenviromental niche for the benefit of the cancer cell.
Journal ArticleDOI

Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes.

TL;DR: Adipose tissue is a source of multipotent stem cells that can be easily isolated, selected, and induced into mature, transplantable hepatocytes, and the fact that they are easy to procure ex vivo in large numbers makes them an attractive tool for clinical studies in the context of establishing an alternative therapy for liver dysfunction.